Back to search
FDAFDA · Food and drugs·Recall number D-1189-2022

Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30.

Published July 20, 2022 · Recall initiated: June 16, 2022

Summary

FDA records drug Class II recall D-1189-2022, published July 20, 2022 and initiated June 16, 2022. Recalling firm: Jubilant Draximage Inc; Status: Terminated; Reported quantity: 519 cartons/30 vials each; Lot: Lot # 1H005, exp. date Nov 30, 2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

What to do

Voluntary: Firm initiated · Letter

Get an email if DRAXIMAGE MAA has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DRAXIMAGE MAA
Manufacturer
Jubilant Draximage Inc
Distributor
Product was distributed to retailers nationwide.
Lot
Lot # 1H005, exp. date Nov 30, 2023
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was Draximage MAA (Kit for the preparation of Technnetium Tc 99m Albumin Aggregate) 2.5 mg per vial, 30 glass vials per carton, Rx Only, Manufactured for Jubilant Draximage Inc. Kirkland, Canada, NDC 65174-270-30. recalled?

Yes. FDA published recall D-1189-2022 on July 20, 2022. Reported hazard: Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DRAXIMAGE MAA.